Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-07-26
DOI
10.1038/srep30093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness evaluation of dendritic cell immunotherapy for osteosarcoma on survival rate and in vitro immune response
- (2015) X. Fang et al. GENETICS AND MOLECULAR RESEARCH
- Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
- (2015) Danielle M. Lussier et al. JOURNAL OF IMMUNOTHERAPY
- Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
- (2015) Abhisek Swaika et al. MOLECULAR IMMUNOLOGY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
- (2015) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma
- (2015) Michael Roth et al. PEDIATRIC BLOOD & CANCER
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts
- (2015) Toru Akiyama et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer
- (2015) Jae Moon Gwak et al. PLoS One
- Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ
- (2014) Jens HW Pahl et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
- (2014) Xiang Chen et al. Cell Reports
- PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2014) H. Wimberly et al. Cancer Immunology Research
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma
- (2014) J. K. Shen et al. Cancer Immunology Research
- Exomics and immunogenics
- (2014) Stéphane Champiat et al. OncoImmunology
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
- (2013) O. K. Afanasiev et al. CLINICAL CANCER RESEARCH
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- New checkpoint inhibitors ride the immunotherapy tsunami
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- PD-1 as a potential target in cancer therapy
- (2013) David F. McDermott et al. Cancer Medicine
- The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis
- (2012) Liliana Endo-Munoz et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
- (2012) Nourredine Himoudi et al. Clinical & Translational Oncology
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- Chromothripsis: Chromosomes in Crisis
- (2012) Mathew J.K. Jones et al. DEVELOPMENTAL CELL
- Lymph Node Metastasis of Osteosarcoma
- (2012) Hiroyuki Hattori et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
- (2012) Qiong-wen Zhang et al. PLoS One
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
- (2011) E. P. Buddingh et al. CLINICAL CANCER RESEARCH
- Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
- (2011) Damya Laoui et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Evaluation of eIF4E Expression in an Osteosarcoma-Specific Tissue Microarray
- (2011) Tanasa S. Osborne et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Addition of pamidronate to chemotherapy for the treatment of osteosarcoma
- (2010) Paul A. Meyers et al. CANCER
- Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases
- (2010) L. Endo-Munoz et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Cryoimmunologic Antitumor Effects Enhanced by Dendritic Cells in Osteosarcoma
- (2010) Masanori Kawano et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma
- (2009) Ayesha Abdeen et al. CANCER
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
- (2008) Tadahiko Kubo et al. CANCER
- Interactions between osteosarcoma cell lines and dendritic cells immune function: An in vitro study
- (2008) Michela Muraro et al. CELLULAR IMMUNOLOGY
- Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients
- (2008) Stefan S. Bielack et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymphatics and bone
- (2007) James R. Edwards et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started